Paeoniflorin inhibits colorectal cancer cell stemness through the miR‐3194‐5p/catenin beta‐interacting protein 1 axis

Author:

Su Zhao1,Hu Beier2,Li Jing1,Zeng Zhichun1,Chen Hu1,Guo Yuhang1,Mao Yun2,Cao Wen2ORCID

Affiliation:

1. The Second Affiliated Hospital of Hunan University of Chinese Medicine Changsha Hunan China

2. Tumor Hematology Department The Second Affiliated Hospital of Hunan University of Chinese Medicine Changsha Hunan China

Abstract

AbstractPaeoniflorin (PF) is a natural plant ingredient with remarkable antitumor effects. Herein, we investigated the biological effects and mechanism of PF in colorectal cancer (CRC) cell stemness. The messenger RNA (mRNA) and protein expressions were assessed using quantitative real‐time polymerase chain reaction and western blot. The viability, proliferation, and migration and invasion of CRC cells were evaluated using cell counting kit‐8, clone‐formation, and transwell migration and invasion assays, respectively. The sphere‐formation capacity was determined using the sphere‐formation assay. A dual‐luciferase reporter gene assay was employed to analyze the interaction between miR‐3194‐5p and catenin beta‐interacting protein 1 (CTNNBIP1). The viability, migration, invasion, epithelial–mesenchymal transition, and stemness of CRC cells were repressed by PF. MiR‐3194‐5p was upregulated in CRC tissues and cells. MiR‐3194‐5p knockdown suppressed CRC cell stemness, while miR‐3194‐5p overexpression had the opposite effect. In addition, the inhibition of CRC cell stemness caused by PF was eliminated by miR‐3194‐5p overexpression. CTNNBIP1 functioned as the target of miR‐3194‐5p, whose knockdown abrogated the repression of CRC cell stemness and Wnt/β‐catenin signaling activation by PF.PF regulated the miR‐3194‐5p/CTNNBIP1/Wnt/β‐catenin axis to repress CRC cell stemness.

Publisher

Wiley

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3